Understanding how bacteria communicate and adapt to their environment
Elucidating Novel Cyclic Nucleotide Signaling Pathways and Physiological Effects in Bacteria
This study is looking at how bacteria communicate and react to their environment, which is important for their survival and ability to cause infections, and it aims to find new ways to help manage bacterial infections by focusing on a special signaling molecule.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State University, the NIH-funded |
| Lab location | 1 site (University Park, United States) |
| Project ID | NIH-11011095 on NIH RePORTER |
What this research studies
This research investigates how bacteria use signaling pathways to respond to their surroundings, which is crucial for their survival and ability to cause infections. By focusing on a specific type of signaling molecule called 2’,3’-cyclic nucleotide monophosphates (2’,3’-cNMPs), the research aims to uncover the mechanisms that control bacterial behavior, including their growth and resistance to stress. The team will employ various laboratory techniques to study these pathways in E. coli and other bacteria, potentially leading to new strategies for managing bacterial infections.
Who could benefit from this research
Good fit: Patients suffering from bacterial infections, particularly those caused by E. coli or similar bacteria, would be ideal candidates to benefit from this research.
Not a fit: Patients with viral infections or non-bacterial diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for bacterial infections by targeting their communication pathways.
How similar studies have performed: Other research has shown promise in targeting bacterial signaling pathways, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
University Park, United States
- Pennsylvania State University, the — University Park, United States (Active)
Researchers
- Principal investigator: Weinert, Emily E — Pennsylvania State University, the
- Study coordinator: Weinert, Emily E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.